150 related articles for article (PubMed ID: 38082393)
1. The comprehensive study on the role of POSTN in fetal congenital heart disease and clinical applications.
Xia Y; Chen L; Lu J; Ma J; Zhang Y
J Transl Med; 2023 Dec; 21(1):901. PubMed ID: 38082393
[TBL] [Abstract][Full Text] [Related]
2. Identification of Gravida Serum Biomarkers for Noninvasive Prenatal Diagnosis Fetal Congenital Heart Disease.
Xia Y; Cheng L; Duan J; Ma J; Zhang Y
J Cardiovasc Transl Res; 2023 Feb; 16(1):255-266. PubMed ID: 36178661
[TBL] [Abstract][Full Text] [Related]
3. Interrogating congenital heart defects with noninvasive fetal echocardiography in a mouse forward genetic screen.
Liu X; Francis R; Kim AJ; Ramirez R; Chen G; Subramanian R; Anderton S; Kim Y; Wong L; Morgan J; Pratt HC; Reinholdt L; Devine W; Leatherbury L; Tobita K; Lo CW
Circ Cardiovasc Imaging; 2014 Jan; 7(1):31-42. PubMed ID: 24319090
[TBL] [Abstract][Full Text] [Related]
4. Why are congenital heart defects being missed?
van Nisselrooij AEL; Teunissen AKK; Clur SA; Rozendaal L; Pajkrt E; Linskens IH; Rammeloo L; van Lith JMM; Blom NA; Haak MC
Ultrasound Obstet Gynecol; 2020 Jun; 55(6):747-757. PubMed ID: 31131945
[TBL] [Abstract][Full Text] [Related]
5. Microcomputed tomography provides high accuracy congenital heart disease diagnosis in neonatal and fetal mice.
Kim AJ; Francis R; Liu X; Devine WA; Ramirez R; Anderton SJ; Wong LY; Faruque F; Gabriel GC; Chung W; Leatherbury L; Tobita K; Lo CW
Circ Cardiovasc Imaging; 2013 Jul; 6(4):551-9. PubMed ID: 23759365
[TBL] [Abstract][Full Text] [Related]
6. Utility of routine screening fetal echocardiogram in pregnancies conceived by in vitro fertilization.
Bjorkman KR; Bjorkman SH; Ferdman DJ; Sfakianaki AK; Copel JA; Bahtiyar MO
Fertil Steril; 2021 Sep; 116(3):801-808. PubMed ID: 34210397
[TBL] [Abstract][Full Text] [Related]
7. [Analysis on echocardiographic data of fetal heart defects at high altitude in Yunnan province and surrounding high altitude areas].
Zhang L; Pan XB; Li L; Shen Y; Li WJ; Zhong DL; Zhao WY; Luo ZL
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jan; 51(1):58-65. PubMed ID: 36655243
[No Abstract] [Full Text] [Related]
8. Clinical study of prenatal ultrasonography combined with T‑box transcription factor 1 as a biomarker for the diagnosis of congenital heart disease.
Guo B; Xiao J; Li L; Wang S; Wang L; Liu S
Mol Med Rep; 2018 May; 17(5):7346-7350. PubMed ID: 29568912
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of repeat fetal echocardiography in congenital heart disease.
Barris DM; Mikhno M; Kornblit M; Wang K; Duong S; Cohen J; Paul E; Stern K; Ezon D; Geiger M
Ultrasound Obstet Gynecol; 2023 Nov; 62(5):695-700. PubMed ID: 37128164
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy loss in major fetal congenital heart disease: incidence, risk factors and timing.
Jepson BM; Metz TD; Miller TA; Son SL; Ou Z; Presson AP; Nance A; Pinto NM
Ultrasound Obstet Gynecol; 2023 Jul; 62(1):75-87. PubMed ID: 37099500
[TBL] [Abstract][Full Text] [Related]
11. Impact of maternal social vulnerability and timing of prenatal care on outcome of prenatally detected congenital heart disease.
Perez MT; Bucholz E; Asimacopoulos E; Ferraro AM; Salem SM; Schauer J; Holleman C; Sekhavat S; Tworetzky W; Powell AJ; Sleeper LA; Beroukhim RS
Ultrasound Obstet Gynecol; 2022 Sep; 60(3):346-358. PubMed ID: 35061294
[TBL] [Abstract][Full Text] [Related]
12. Prenatal diagnosis of congenital fetal heart abnormalities and clinical analysis.
Li H; Wei J; Ma Y; Shang T
J Zhejiang Univ Sci B; 2005 Sep; 6(9):903-6. PubMed ID: 16130193
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis and pregnancy outcomes of 1492 fetuses with congenital heart disease: role of multidisciplinary-joint consultation in prenatal diagnosis.
Qiu X; Weng Z; Liu M; Chen X; Wu Q; Ling W; Ma H; Huang H; Lin Y
Sci Rep; 2020 May; 10(1):7564. PubMed ID: 32371943
[TBL] [Abstract][Full Text] [Related]
14. Risk of Congenital Heart Disease in Newborns with Prenatal Exposure to Anti-depressant Medications.
Desai PH; Yagnik PJ; Ross Ascuitto N; Prajapati P; Sernich S
Cureus; 2019 May; 11(5):e4673. PubMed ID: 31328065
[TBL] [Abstract][Full Text] [Related]
15. [Results of prenatal screening for fetal chromosome abnormality during the first trimester pregnancy in Guangzhou].
Xu Z; Li B; Liao C; Sun Q; Bai X; Li D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Oct; 31(5):632-5. PubMed ID: 25297598
[TBL] [Abstract][Full Text] [Related]
16. Prenatal Atrioventricular Septal Defect (AVSD) as a planned congenital heart disease with different outcome depending on the presence of the coexisting extracardiac abnormalities (ECA) and/or malformations (ECM).
Słodki M; Soroka M; Rizzo G; Respondek-Liberska M;
J Matern Fetal Neonatal Med; 2020 Aug; 33(15):2635-2641. PubMed ID: 30514144
[No Abstract] [Full Text] [Related]
17. Utility of Screening Fetal Echocardiograms at a Single Institution Following Normal Obstetric Ultrasound in Fetuses with Down Syndrome.
Taylor K; Lovelace C; Richards B; Tseng S; Ogunleye O; Cua CL
Pediatr Cardiol; 2023 Oct; 44(7):1514-1519. PubMed ID: 37351603
[TBL] [Abstract][Full Text] [Related]
18. A prospective cohort study on association of first-trimester serum biomarkers and risk of isolated foetal congenital heart defects.
Hematian MN; Hessami K; Torabi S; Saleh M; Nouri B; Saleh M
Biomarkers; 2021 Dec; 26(8):747-751. PubMed ID: 34645361
[TBL] [Abstract][Full Text] [Related]
19. Fetal Tricuspid Regurgitation in the First Trimester as a Screening Marker for Congenital Heart Defects: Systematic Review and Meta-Analysis.
Scala C; Morlando M; Familiari A; Leone Roberti Maggiore U; Ferrero S; D'Antonio F; Khalil A
Fetal Diagn Ther; 2017; 42(1):1-8. PubMed ID: 28482343
[TBL] [Abstract][Full Text] [Related]
20. Association Analysis between Maternal Serum Biomarkers and Fetal Congenital Heart Disease.
Jiang H; Lin Y; He X
Heart Surg Forum; 2023 Oct; 26(5):E552-E559. PubMed ID: 37920073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
